Skip to search formSkip to main contentSkip to account menu

NSC-145,668

Known as: NSC145,668, NSC 145668, NSC145668 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Ancitabineancitabine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
Letter: Myelotoxicity and orthostatic hypotension of cyclocytidine (NSC-145668).
1975
1975
Phase I. evaluation of cyclocytidine (NSC-145668).
Cyclocytidine is a repository form of cytosine arabinoside and has a prolonged plasma half-life (8 hours) compared to cytosine… 
1975
1975
Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.
The distribution of cyclocytidine and cytosine arabinoside has been studied in normal BDF mice and in mice bearing 6-day solid… 
1975
1975
Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.
The distribution of cyclocytidine and cytosine arabinoside has been studied in normal BDF mice and in mice bearing 6-day solid… 
1975
1975
Evaluation of sialogogic action of cyclocytidine (NSC-145668) and anhydro-ara-5-fluorocytidine (NSC-166641).
1974
1974
Synthesis and biologic examination of some derivatives of 2,2'-anhydro-1-(beta-d-arabinofuranosyl)cytosine hydrochloride (NSC-145668).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)